Reply to "An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2"
- PMID: 34396573
- PMCID: PMC8365250
- DOI: 10.15252/embj.2020107517
Reply to "An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2"
Abstract
Figures
Comment in
-
Response to Veitia et al.EMBO J. 2021 Aug 16;40(16):e108671. doi: 10.15252/embj.2021108671. EMBO J. 2021. PMID: 34396572 Free PMC article.
Comment on
-
An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.EMBO J. 2020 Dec 15;39(24):e104719. doi: 10.15252/embj.2020104719. Epub 2020 Nov 20. EMBO J. 2020. PMID: 33215742 Free PMC article.
References
-
- Benayoun BA, Kalfa N, Sultan C, Veitia RA (2010) The forkhead factor FOXL2: a novel tumor suppressor? Biochim Biophys Acta 1805: 1–5 - PubMed
-
- Carles A, Trigo‐Gonzalez G, Cao Q, Cheng S‐WG, Moksa M, Bilenky M, Huntsman DG, Morin GB, Hirst M (2020) The pathognomonic FOXL2 C134W mutation alters DNA‐binding specificity. Cancer Res 80: 3480–3491 - PubMed
-
- Howard TD, Bleecker ER, Stine OC (1999) Fluorescent allele‐specific PCR (FAS‐PCR) improves the reliability of single nucleotide polymorphism screening. Biotechniques 26: 380–381 - PubMed
-
- Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, Saito M, Nomura M, Mukasa C, Okabe T, Goto Ket al (2001) Establishment and characterization of a steroidogenic human granulosa‐like tumor cell line, KGN, that expresses functional follicle‐stimulating hormone receptor. Endocrinology 142: 437–445 - PubMed
-
- Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SEet al (2009) Mutation of FOXL2 in granulosa‐cell tumors of the ovary. N Engl J Med 360: 2719–2729 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
